[
1. GOODALE T, SADHU A, PETAK S, ROBBINS R. Testosterone and the Heart. Methodist Debakey Cardiovasc J. 2017;13(2):68–72.10.14797/mdcj-13-2-68551268228740585
]Search in Google Scholar
[
2. HU JR, DUNCAN MS, MORGANS AK, BROWN JD, MEIJERS WC, FREIBEG MS, et al. Cardiovascular effects of androgen deprivation therapy in prostate cancer. Arterioscler Thromb Vasc Biol. 2020;40:e55–e64.10.1161/ATVBAHA.119.313046704754931969015
]Search in Google Scholar
[
3. KAUR H, GH WERSTUCK. The effect of testosterone on cardiovascular disease and cardiovascular risk factors in men: A review of clinical and preclinical data. CJC Open. 2021:1238–1248.10.1016/j.cjco.2021.05.007863624434888506
]Search in Google Scholar
[
4. ELAGIZI A, KOHLER TS, LAVIE CJ. Testosterone and Cardiovascular Health. Mayo Clinic Proceedings. 2018;93(1):83–100.10.1016/j.mayocp.2017.11.00629275030
]Search in Google Scholar
[
5. DANDONA P, DHINDSA S, GHANIM H, SAAD F. Mechanisms underlying the metabolic actions of testosterone in humans: A narrative review. Diabetes Obes Metab. 2021;23(1):18–28.10.1111/dom.1420632991053
]Search in Google Scholar
[
6. Testosterone replacement therapy benefits outweigh risks, say researchers. American Association of Clinical Endocrinologists website, http://media.aace.com/press-release/aaceannualmeeting-press-releases/testosterone-replacement-therapy-benefitsoutweigh -.Accessed October 27, 2017.
]Search in Google Scholar
[
7. SHORES MM, MATSUMOTO AM. Testosterone, aging and survival: biomarker or deficiency. Curr Opin Endocrinol Diabetes Obes. 2014;21(3):209–216.10.1097/MED.0000000000000057431376524722173
]Search in Google Scholar
[
8. OHLSSON C, BARRETT-CONNOR E, BHASIN S, et al. High serum testosterone is associated with reduced risk of cardiovascular events in elderly men. J Am Coll Cardiol. 2011;58(16):1674–1681.10.1016/j.jacc.2011.07.01921982312
]Search in Google Scholar
[
9. KLONER RA, CARSON C, DOBS A, KOPECKY S, MOHLER ER. Testosterone and cardiovascular disease. J Am Coll Cardiol. 2016;67(5):545–557.10.1016/j.jacc.2015.12.00526846952
]Search in Google Scholar
[
10. UKKOLA O, HUTTUNEN T, PUURUNEN VP, PIIRA O, NIVA J, LEPOJARVI S, et al. Total testosterone levels, metabolic parameters, cardiac remodeling and exercise capacity in coronary artery disease patients with different stages of glucose tolerance. Ann Med. 2013;45(3):206–212.10.3109/07853890.2012.71195123548167
]Search in Google Scholar
[
11. MALKIN CJ, PUGH PJ, MORRIS PD, ASIF S, JONES TH, CHANNER KS. Low serum testosterone and increased mortality in men with coronary heart disease. Heart. 2010;96(22):1821–1825.10.1136/hrt.2010.19541220959649
]Search in Google Scholar
[
12. OSKUI PM, FRENCH WJ, HERRING MJ, MAYEDA GS, BURSTEIN S, KLONER R. Testosterone and the cardiovascular system: a comprehensive review of the clinical literature. J Am Heart Assoc. 2013;2(6):e000272.10.1161/JAHA.113.000272388677024242682
]Search in Google Scholar
[
13. ORY J, NACKEERAN S, BALAJI NC, HARE JM, RAMASAMY AR. Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy. J Urol. 2022;207(6):1295–1301.10.1097/JU.000000000000243735050717
]Search in Google Scholar
[
14. FALLARA G, POZZI E, BELLADELLI F, CORSINI C, BOERI L, CAPOGROSSO P, et al. Cardiovascular Morbidity and Mortality in Men - Findings From a Meta-analysis on the Time-related Measure of Risk of Exogenous Testosterone. J Sex Med. 2022;19(8):1243–1254.10.1016/j.jsxm.2022.05.14535753891
]Search in Google Scholar
[
15. GAGLIONI-JUCA T, BASARIA S. Testosterone replacement therapy and cardiovascular risk. Nature /Reviews. 2019;16:555–574.
]Search in Google Scholar
[
16. AUKRUST P, UELAND T, GULLESTAD L, YNDESTAD A. Testosterone: a novel therapeutic approach in chronic heart failure? J Am Coll Cardiol. 2009 Sep 1;54(10):928–9.10.1016/j.jacc.2009.05.03919712803
]Search in Google Scholar
[
17. JANKOWSKA EA, TKACZYSZYN M, KALICIŃSKA E, BANASIAK W, PONIKOWSKI P. Testosterone deficiency in men with heart failure: pathophysiology and its clinical, prognostic and therapeutic implications. Kardiol Pol. 2014;72(5):403–9.10.5603/KP.a2014.002524526551
]Search in Google Scholar
[
18. PUGH PJ, JONES RD, WEST JN, JONES TH, CHANNER KS. Testosterone treatment for men with chronic heart failure. Heart. 2004;90(4):446–447.10.1136/hrt.2003.014639176816115020527
]Search in Google Scholar
[
19. TOMA M, MCALISTER FA, COGLIANESE EE, VIDI V, VAISAWALA S, BAKAL JA, et al. Testosterone supplementation in heart failure: a meta-analysis. Circ Heart Fail. 2012;5(3):315–321.10.1161/CIRCHEARTFAILURE.111.96563222511747
]Search in Google Scholar
[
20. CAMINITI G, VOLTERRANI M, IELLAMO F, MARAZZI G, MASSARO R, MICELLI M, et al. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure. J Am Coll Cardiol.2009;54(10):919–927.10.1016/j.jacc.2009.04.07819712802
]Search in Google Scholar
[
21. NJOROGE JN, TRESSEL W, BIGGS ML, MATSUMOTO AM, SMITH NL, ROSENBERG E, et al. Circulating Androgen Concentrations and Risk of Incident Heart Failure in Older Men: The Cardiovascular Health Study. J Am Heart Assoc. 2022 Nov;11(21):e026953.10.1161/JAHA.122.026953967363636285783
]Search in Google Scholar
[
22. OSKUI PM, FRENCH WJ, HERRING MJ, MAYEDA GS, BURSTEIN S, KLONER R. Testosterone and the cardiovascular system: a comprehensive review of the clinical literature. J Am Heart Assoc. 2013;2(6):e000272.10.1161/JAHA.113.000272
]Search in Google Scholar
[
23. LAI J, GE Y, SHAO Y, XUAN T, XIA S, LI M. Low serum testosterone level was associated with extensive coronary artery calcification in elderly male patients with stable coronary artery disease. Coron Artery Dis. 2015;26(5):437–441.10.1097/MCA.000000000000026025968306
]Search in Google Scholar
[
24. PARK BJ, SHIM JY, LEE YJ, LEE JH, LEE HR. Inverse relationship between bioavailable testosterone and subclinical coronary artery calcification in non-obese Korean men. Asian J Androl. 2012;14(4):612–615.10.1038/aja.2012.19372006722522505
]Search in Google Scholar
[
25. TURHAN S, TULUNAY C, GÜLEC S, OZDOL C, KILICKAP M, ALTIN T, et al. The association between androgen levels and premature coronary artery disease in men. Coron Artery Dis. 2007;18(3):159–162.10.1097/MCA.0b013e328012a92817429287
]Search in Google Scholar
[
26. MATHUR A, MALKIN C, SAEED B, MUTHUSAMY R, JONES TH, CHANNER K. Long-term benefits of testosterone replacement therapy on angina threshold and atheroma in men. Eur J Endocrinol. 2009;161(3):443–449.10.1530/EJE-09-009219542238
]Search in Google Scholar
[
27. BUDOFF MJ, ELLENBERG SS, LEWIS CE, MOHLER ER, WENGER NK, BHASIN S, et al. Testosterone treatment and coronary artery plaque volume in older men with low testosterone. JAMA. 2017;317(7):708–716.10.1001/jama.2016.21043546543028241355
]Search in Google Scholar
[
28. ALEXANDER GC, IYER G, LUCAS E, LIN D, SINGH S. Cardiovascular risks of exogenous testosterone use among men: a systematic review and meta-analysis. Am J Med. 2017;130(3):293–305.10.1016/j.amjmed.2016.09.01727751897
]Search in Google Scholar
[
29. ENGLISH KM, STEEDS RP, JONES TH, DIVER MJ, CHANNER KS. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study. Circulation. 2000 Oct 17;102(16):190610.1161/01.CIR.102.16.1906
]Search in Google Scholar
[
30. ROSANO GM, LEONARDO F, PAGNOTTA P, PELLICCIA F, PANINA G, CARQUETANI E, et al. Acute anti-ischemic effect of testosterone in men with coronary artery disease. Circulation. 1999 Apr 6;99(13):1666–70.10.1161/01.CIR.99.13.1666
]Search in Google Scholar
[
31. WEBB CM, ADAMSON DL, DE ZEIGLER D, COLLINS P. Effect of acute testosterone on myocardial ischemia in men with coronary artery disease. Am J Cardiol. 1999 Feb 1;83(3):437–9, A9.
]Search in Google Scholar
[
32. MORLEY JE, PERRY HM III. Androgens and women at the menopause and beyond. J Gerontol A Biol Sci Med Sci. 2003;58(5):M409–M416.10.1093/gerona/58.5.M409
]Search in Google Scholar
[
33. BRAND JS, VAN DER SCHOUW YT. Testosterone, SHBG and cardiovascular health in postmenopausal women. Int J Impot Res. 2010;22(2):91–104.10.1038/ijir.2009.6420090761
]Search in Google Scholar
[
34. ELRAIYAH T, SONBOL MB, WANG Z, KHAIRALSEED T, ASI N, UNDAVALLI C, et al. Clinical review: The benefits and harms of systemic testosterone therapy in postmenopausal women with normal adrenal function: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2014 Oct;99(10):3543–50.10.1210/jc.2014-2262539349525279572
]Search in Google Scholar
[
35. SPOLETINI I, VITALE C, PELLICCIA F, FOSSATI C, ROSANO GM. Androgens and cardiovascular disease in postmenopausal women: a systematic review. Climacteric. 2014; 17(6):625-34. doi: 10.3109/13697137.2014.887669.24559253
]Open DOISearch in Google Scholar
[
36. SHUFELT CL, BRAUNSTEIN GD. Safety of testosterone use in women. Maturitas. 2009;63(1):63–6.10.1016/j.maturitas.2009.01.01219250779
]Search in Google Scholar
[
37. LEE JH, SHAH PH, UMA D, SALVI DJ, RABBANI R, HAMID P. Testosterone Replacement Therapy in Hypogonadal Men and Myocardial Infarction Risk: Systematic Review & Meta-Analysis. Cureus. 2021;13(8):e17475.10.7759/cureus.17475840517434513525
]Search in Google Scholar
[
38. NGUYEN CP, HIRSCH MS, MOENY D, KAUL S, MOHAMOUD M, JOFFE HV. Testosterone and “Age-Related Hypogonadism”--FDA Concerns. N Engl J Med. 2015 Aug 20;373(8):689–91.10.1056/NEJMp1506632890539926287846
]Search in Google Scholar
